Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Perlman

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Neurology and Therapy|February 18, 2026
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)Michele H Potashman, Basia M Rogula, Lauren C Powell, et al.
Journal of Child Neurology|April 14, 2016
Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone DeficiencyJulianna E Shinnick, Kimberly Schadt, Cassandra Strawser, et al.
Annals of Neurology|December 26, 2015
Compound heterozygous FXN mutations and clinical outcome in friedreich ataxiaCharles A Galea, Aamira Huq, Paul J Lockhart, et al.
Neurology. Genetics|November 17, 2021
Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures StudyMaya Patel, Ashley McCormick, Jaclyn Tamaroff, et al.
Annals of Clinical and Translational Neurology|September 5, 2015
Frataxin levels in peripheral tissue in Friedreich ataxiaMichael Lazaropoulos, Yina Dong, Elisia Clark, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
JAMA Cardiology|June 17, 2026
AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical TrialRonald G Crystal, Jonathan W Weinsaft, Stephen M Kaminsky, et al.
Orphanet Journal of Rare Diseases|November 15, 2013
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational studyTetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, et al.
Annals of Neurology|April 24, 2012
FXN methylation predicts expression and clinical outcome in Friedreich ataxiaMarguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Neurology and Therapy|February 18, 2026
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)Michele H Potashman, Basia M Rogula, Lauren C Powell, et al.
Journal of Child Neurology|April 14, 2016
Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone DeficiencyJulianna E Shinnick, Kimberly Schadt, Cassandra Strawser, et al.
Annals of Neurology|December 26, 2015
Compound heterozygous FXN mutations and clinical outcome in friedreich ataxiaCharles A Galea, Aamira Huq, Paul J Lockhart, et al.
Neurology. Genetics|November 17, 2021
Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures StudyMaya Patel, Ashley McCormick, Jaclyn Tamaroff, et al.
Annals of Clinical and Translational Neurology|September 5, 2015
Frataxin levels in peripheral tissue in Friedreich ataxiaMichael Lazaropoulos, Yina Dong, Elisia Clark, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
JAMA Cardiology|June 17, 2026
AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical TrialRonald G Crystal, Jonathan W Weinsaft, Stephen M Kaminsky, et al.
Orphanet Journal of Rare Diseases|November 15, 2013
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational studyTetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, et al.
Annals of Neurology|April 24, 2012
FXN methylation predicts expression and clinical outcome in Friedreich ataxiaMarguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Pageof 6